title: Shrinkage temperature and anti-calcification property of triglycidylamine-crosslinked autologous tissue.
abstract: Since bioprosthetic valve dysfunction may arise due to histological calcification in the crosslinking process by glutaraldehyde (GA), non-GA crosslinking reagents have been investigated. We compared the efficacy of triglycidylamine (TGA), a newly synthesized epoxy compound, and GA as crosslinking reagents for the treatment of autologous tissues. We assessed the strength of crosslinked tissues using shrinkage temperature (Ts) measured by differential scanning calorimetry. We also conducted subdermal allografting of the crosslinked pericardium and thoracic aorta in rats, and verified the anti-calcification efficacy of TGA by histological evaluations with von Kossa stain, and immunological evaluations using tenascin-C (TN-C) or matrix metalloproteinase-9 (MMP-9). TGA treatment resulted in slower increases in Ts of the pericardium, and it required 9-12 h to reach Ts achieved by GA. In subdermal implantation of rat tissues, calcium content was lower in the TGA group than in the GA groups (p < 0.005). The expression site of TN-C and MMP-9 differed from the primary location of calcium deposition in the thoracic aorta treated with TGA suggesting a different underlying mechanism in calcification between GA and TGA crosslinking. In conclusion, TGA crosslinking in the allograft showed superior anti-calcification effect as compared to brief treatment by GA, although TGA crosslinking process was slow.
authors.affiliation: Department of Cardiovascular Surgery, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, 305-8575, Japan.
authors.forename: Masataka
authors.initials: M
authors.lastname: Sato
authors.forename: Yuji
authors.initials: Y
authors.lastname: Hiramatsu
authors.forename: Shonosuke
authors.initials: S
authors.lastname: Matsushita
authors.forename: Shoko
authors.initials: S
authors.lastname: Sato
authors.forename: Yasunori
authors.initials: Y
authors.lastname: Watanabe
authors.forename: Yuzuru
authors.initials: Y
authors.lastname: Sakakibara
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000637:transplantation*; D001705:Bioprosthesis; D002114:Calcinosis / Q000378:metabolism / Q000517:prevention & control*; D003432:Cross-Linking Reagents / Q000494:pharmacology; D004195:Disease Models, Animal; D004852:Epoxy Compounds / Q000494:pharmacology*; D005976:Glutaral / Q000494:pharmacology*; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D010496:Pericardium / Q000187:drug effects / Q000637:transplantation*; D051381:Rats; D017208:Rats, Wistar; D013696:Temperature; D014182:Transplantation, Autologous
chemical_list: D003432:Cross-Linking Reagents; D004852:Epoxy Compounds; C516444:triglycidylamine; D005976:Glutaral